|

Alzheimer's Disease Clinical Trials in Florida

56 recruiting studies across 4 cities

Browse by City

Miami
42 trials
Orlando
34 trials
Tampa
22 trials
Jacksonville
9 trials

All Trials in Florida

Phase
Trial Phase Dist.
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's DiseasePhase 4<1 mi
Preventing Alzheimer's With Cognitive TrainingPhase 3<1 mi
[18F]PI-2620 Phase 3 Histopathological StudyPhase 3<1 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)Phase 3<1 mi
Dominantly Inherited Alzheimer Network (DIAN)—<1 mi
Robotic-Enabled Microsurgical Intervention for Neurodegenerative DiseaseN/A<1 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol—<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3<1 mi
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPhase 1/2<1 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)Phase 3<1 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaPhase 2<1 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)Phase 3<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3<1 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseasePhase 2<1 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 3<1 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 2<1 mi
ACP-204 in Adults With Alzheimer's Disease PsychosisPhase 2/3<1 mi
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypePhase 3<1 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3<1 mi
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's DiseaseN/A<1 mi
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia—<1 mi
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseasePhase 2<1 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Phase 3<1 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 3<1 mi
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Phase 2<1 mi
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseasePhase 2<1 mi
University of Central Florida Music StudyN/A<1 mi
University of Central Florida CereBank—<1 mi
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)Phase 1/2<1 mi
Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseasePhase 1/2<1 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Phase 3<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
Clinical Trial on Agitation in Alzheimer's DementiaPhase 2<1 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)N/A<1 mi
Late Onset Alzheimer's Disease—<1 mi
Combating Alzheimer's Through Sleep and ExerciseN/A<1 mi
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.Phase 2<1 mi
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among BlacksN/A<1 mi
Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.Phase 2<1 mi
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy—<1 mi
Open-label Extension Study in Participants With Early Alzheimer's DiseasePhase 2<1 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Phase 2<1 mi
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisPhase 2<1 mi
Longitudinal Cognitive Assessment by BoCA—<1 mi
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseasePhase 25 mi
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseasePhase 16 mi
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)Phase 16 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseasePhase 314 mi
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's TypePhase 218 mi
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia—34 mi
Neurologic Stem Cell Treatment StudyN/A36 mi
Brain NAD in Alzheimer's Disease—42 mi
Digital Detection of Dementia (D Cubed) Studies: D3N/A42 mi
Pulsed Electromagnetic Field Treatment With Dementia PatientsN/A42 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.